IL312625A - Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditions - Google Patents

Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditions

Info

Publication number
IL312625A
IL312625A IL312625A IL31262524A IL312625A IL 312625 A IL312625 A IL 312625A IL 312625 A IL312625 A IL 312625A IL 31262524 A IL31262524 A IL 31262524A IL 312625 A IL312625 A IL 312625A
Authority
IL
Israel
Prior art keywords
imidazo
crystalline
pharmaceutical compositions
medical conditions
pyridine compound
Prior art date
Application number
IL312625A
Other languages
English (en)
Hebrew (he)
Inventor
Benoit Robert
Original Assignee
Genzyme Corp
Benoit Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Benoit Robert filed Critical Genzyme Corp
Publication of IL312625A publication Critical patent/IL312625A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL312625A 2021-11-12 2022-11-11 Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditions IL312625A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21207942.0A EP4180428A1 (en) 2021-11-12 2021-11-12 Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions
PCT/US2022/049695 WO2023086564A1 (en) 2021-11-12 2022-11-11 Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions

Publications (1)

Publication Number Publication Date
IL312625A true IL312625A (en) 2024-07-01

Family

ID=78617277

Family Applications (1)

Application Number Title Priority Date Filing Date
IL312625A IL312625A (en) 2021-11-12 2022-11-11 Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditions

Country Status (10)

Country Link
US (3) US11814383B2 (https=)
EP (2) EP4180428A1 (https=)
JP (1) JP2024543413A (https=)
CN (1) CN118843624A (https=)
AU (1) AU2022387516A1 (https=)
CA (1) CA3237156A1 (https=)
IL (1) IL312625A (https=)
MX (1) MX2024005766A (https=)
TW (1) TW202334143A (https=)
WO (1) WO2023086564A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI731317B (zh) * 2013-12-10 2021-06-21 美商健臻公司 原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
EP4180428A1 (en) 2021-11-12 2023-05-17 Genzyme Corporation Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions
CN121464134A (zh) * 2023-05-17 2026-02-03 中枢疗法公司 咪唑并[4,5-b]吡啶化合物的颗粒、药物组合物及其在治疗医学病症中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI731317B (zh) 2013-12-10 2021-06-21 美商健臻公司 原肌球蛋白相關之激酶（ｔｒｋ）抑制劑
EA201791336A1 (ru) 2014-12-18 2017-10-31 Джензим Корпорейшн Фармацевтические составы на основе ингибиторов тропомиозин-родственных киназ (trk)
WO2019084285A1 (en) 2017-10-26 2019-05-02 Qian Zhao FORMULATIONS OF A MACROCYCLIC TRK KINASE INHIBITOR
WO2019191659A1 (en) 2018-03-29 2019-10-03 Loxo Oncology, Inc. Treatment of trk-associated cancers
JP7472103B2 (ja) * 2018-08-22 2024-04-22 クルゲン（シャンハイ），インク． トロポミオシン受容体キナーゼ（ｔｒｋ）分解化合物とその使用方法
EP4110772A4 (en) 2020-02-26 2024-04-03 Cullgen (Shanghai), Inc. TROPOMYOSIN RECEPTOR KINASE (TRK) DEGRADATION COMPOUNDS AND METHODS OF USE
EP4180428A1 (en) 2021-11-12 2023-05-17 Genzyme Corporation Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions

Also Published As

Publication number Publication date
TW202334143A (zh) 2023-09-01
JP2024543413A (ja) 2024-11-21
US20250250274A1 (en) 2025-08-07
WO2023086564A1 (en) 2023-05-19
CN118843624A (zh) 2024-10-25
US11814383B2 (en) 2023-11-14
EP4180428A1 (en) 2023-05-17
AU2022387516A1 (en) 2024-05-23
US12291528B2 (en) 2025-05-06
EP4430043A1 (en) 2024-09-18
EP4430043A4 (en) 2025-11-05
MX2024005766A (es) 2024-07-29
US20230151008A1 (en) 2023-05-18
US20240150352A1 (en) 2024-05-09
CA3237156A1 (en) 2023-05-19

Similar Documents

Publication Publication Date Title
IL312625A (en) Crystalline compounds of imidazo[5,4-b]pyridine, pharmaceutical compositions, and their uses in the treatment of medical conditions
IL289164A (en) The history of imidazo[2,1-a)pyridinyl and their use in the treatment of diseases
MY150216A (en) Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
IL196243A (en) [4,2,1] Triazole [3,4– a Pyridine Derivatives
CA3261509A1 (en) CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
IL210689A0 (en) Novel imidazo [1, 2 - a] pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
IL288872B1 (en) IMIDAZO[1,5-c]PYRIMIDIN-5-AMINE PERI-CONDENSED DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USES IN CANCER TREATMENT
IL172192A0 (en) Pyridino [1,2 - a] pyrimidin - 4 - one compounds as anticancer agents
WO2009143156A3 (en) Imidazo [1, 2-a] pyridine compounds as gaba-a receptor modulators
MY148583A (en) Pyridine [3,4-b] pyrazinones
IL197243A (en) Derivatives of 2-amino, 4-methyl, 8-cycloalkyl @ pyrido @ [@@@ - d] @ pyrimidine-7-on, medicinal preparations containing them and their use in the preparation of @ drugs @ for treatment @ growth @ abnormal @ of @ cell @ Beyonc
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
IL207038A (en) History of Diazaspiro [5.5] Undecan, Pharmaceuticals Containing them, and their use in the preparation of drugs for the treatment or reduction of the risk of disease or inflammatory condition
PT2872510T (pt) Derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infeções bacterianas
WO2005000232A3 (en) Six membered amino-amide derivatives as angiogenesis inhibitors
UA94901C2 (ru) Антибактериальные производные пиперидина
ZA201200705B (en) Imidazo [4,5-c]quinoline derivatives and their use in the treatment of tumors and/or inflammation
IL215074A0 (en) Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
WO2006126082A3 (en) Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2021009676A8 (en) Imidazo[4,5-c]pyridine derivatives as toll-like receptor agonists
MX2009012109A (es) Composiciones contra el insomnio y metodos.
EP4516318A3 (en) 1-isopropyl-3-methyl-8- (pyridin-3-yl) -1, 3-dihydro-2h-imidazo [4, 5-c] cinnolin-2-one as selective modulators of ataxia telangiectasia mutated (atm) kinase and uses thereof
SG10201809189UA (en) 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one, salts thereof and methods of use
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application